The ALC Technology portfolio utilizes 3 point of care autologous preparation systems that provide new advanced solutions for the creation of safer, more cost-effective biological solutions over existing industry standards.
The Maxx-Cell® system maximizes the yield of stem and progenitor cells by giving the clinician the ability to efficiently harvest bone marrow from multiple levels within the medullary space, while restricting dilution of peripheral blood.
CUSTOMIZABLE PRP AT YOUR FINGERTIPS TO TREAT A VARIETY OF CONDITIONS.
Maxx™ PRP provides a 4-6x level over baseline concentration of platelets, promoting the following growth factors:
VEGF - Vascular Endothelial Growth Factors
PDGF - Platelet Derived Growth Factors
TGF - Transforming Growth Factors